304 related articles for article (PubMed ID: 15888295)
1. Toxocara canis: search for a potential drug amongst beta-carboline alkaloids--in vitro and mouse studies.
Satou T; Horiuchi A; Akao N; Koike K; Fujita K; Nikaido T
Exp Parasitol; 2005 Jun; 110(2):134-9. PubMed ID: 15888295
[TBL] [Abstract][Full Text] [Related]
2. The effect of free and polyethylene glycol-liposome-entrapped albendazole on larval mobility and number in Toxocara canis infected mice.
Horiuchi A; Satou T; Akao N; Koike K; Fujita K; Nikaido T
Vet Parasitol; 2005 Apr; 129(1-2):83-7. PubMed ID: 15817207
[TBL] [Abstract][Full Text] [Related]
3. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection.
Leonardi D; Echenique C; Lamas MC; Salomon CJ
J Antimicrob Chemother; 2009 Aug; 64(2):375-8. PubMed ID: 19497941
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans.
Barrera MG; Leonardi D; Bolmaro RE; Echenique CG; Olivieri AC; Salomon CJ; Lamas MC
Eur J Pharm Biopharm; 2010 Aug; 75(3):451-4. PubMed ID: 20347973
[TBL] [Abstract][Full Text] [Related]
5. Toxocara canis: potential activity of natural products against second-stage larvae in vitro and in vivo.
Reis M; Trinca A; Ferreira MJ; Monsalve-Puello AR; Grácio MA
Exp Parasitol; 2010 Oct; 126(2):191-7. PubMed ID: 20447397
[TBL] [Abstract][Full Text] [Related]
6. An improved method for recovery of muscle-stage larvae from mice infected with Toxocara canis.
Jin Z; Akao N; Nobuta T; Ohta N
J Parasitol; 2008 Oct; 94(5):1164-5. PubMed ID: 18576836
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of follow-up of therapy with fenbendazole incorporated into stabilized liposomes and immunomodulator glucan in mice infected with Toxocara canis larvae.
Hrckova G; Velebný S; Obwaller A; Auer H; Kogan G
Acta Trop; 2007; 104(2-3):122-32. PubMed ID: 17915186
[TBL] [Abstract][Full Text] [Related]
8. Larval migration of Toxocara canis in piglets and transfer of larvae from infected porcine tissue to mice.
Sasmal NK; Acharya S; Laha R
J Helminthol; 2008 Sep; 82(3):245-9. PubMed ID: 18416883
[TBL] [Abstract][Full Text] [Related]
9. Toxocara canis: anthelmintic activity of quinone derivatives in murine toxocarosis.
Mata-Santos T; Mata-Santos HA; Carneiro PF; De Moura KC; Fenalti JM; Klafke GB; Cruz LA; Martins LH; Pinto NF; Pinto MC; Berne ME; Da Silva PE; Scaini CJ
Parasitology; 2016 Apr; 143(4):507-17. PubMed ID: 26887285
[TBL] [Abstract][Full Text] [Related]
10. Anthelmintic effect of levamisole, ivermectin, albendazole and fenbendazole on larval Toxocara canis infection in mice.
Abo-Shehada MN; Herbert IV
Res Vet Sci; 1984 Jan; 36(1):87-91. PubMed ID: 6546805
[TBL] [Abstract][Full Text] [Related]
11. An improved method to obtain antigen-excreting Toxocara canis larvae.
Alcântara-Neves NM; dos Santos AB; Mendonça LR; Figueiredo CA; Pontes-de-Carvalho L
Exp Parasitol; 2008 Jul; 119(3):349-51. PubMed ID: 18439580
[TBL] [Abstract][Full Text] [Related]
12. Anthelmintic activity of benzimidazole derivatives against Toxocara canis second-stage larvae and Hymenolepis nana adults.
Márquez-Navarro A; Nogueda-Torres B; Hernández-Campos A; Soria-Arteche O; Castillo R; Rodríguez-Morales S; Yépez-Mulia L; Hernández-Luis F
Acta Trop; 2009 Mar; 109(3):232-5. PubMed ID: 19073130
[TBL] [Abstract][Full Text] [Related]
13. Effect of thiabendazole on the migration of Toxocara canis larvae in the mouse.
Abdel-Hameed AA
J Parasitol; 1984 Apr; 70(2):226-31. PubMed ID: 6470886
[TBL] [Abstract][Full Text] [Related]
14. Influence of Toxocara canis infection during pregnancy on offspring resistance towards re-infection.
Reiterová K; Tomasovicová O; Dubinský P
Parasitology; 2006 May; 132(Pt 5):625-33. PubMed ID: 16426482
[TBL] [Abstract][Full Text] [Related]
15. Alterations of plasma circulating microRNAs in BALB/c mice with Toxocara canis visceral and cerebral larva migrans.
Yang Y; Chen Y; Zheng Z; Lin L; Chen X; Yang C; Zhong D; Wu H; Xiong Z; Liu S; Wang T; Yang Y; Du A; Ma G
Parasit Vectors; 2024 Jun; 17(1):256. PubMed ID: 38867315
[TBL] [Abstract][Full Text] [Related]
16. A murine model for cerebral toxocariasis: characterization of host susceptibility and behaviour.
Hamilton CM; Stafford P; Pinelli E; Holland CV
Parasitology; 2006 Jun; 132(Pt 6):791-801. PubMed ID: 16476184
[TBL] [Abstract][Full Text] [Related]
17. Effect of fenbendazole on Toxocara canis larvae in tissues of infected dogs.
Dubey JP
Am J Vet Res; 1979 May; 40(5):698-9. PubMed ID: 475114
[TBL] [Abstract][Full Text] [Related]
18. Patent Toxocara canis infections in previously exposed and in helminth-free dogs after infection with low numbers of embryonated eggs.
Fahrion AS; Staebler S; Deplazes P
Vet Parasitol; 2008 Mar; 152(1-2):108-15. PubMed ID: 18201825
[TBL] [Abstract][Full Text] [Related]
19. Effects of disinfectants on Toxocara canis embryogenesis and larval establishment in mice tissues.
Verocai GG; Tavares PV; Ribeiro Fde A; Correia TR; Scott FB
Zoonoses Public Health; 2010 Dec; 57(7-8):e213-6. PubMed ID: 20500505
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of isoquinoline alkaloids on movement of second-stage larvae of Toxocara canis.
Satou T; Akao N; Matsuhashi R; Koike K; Fujita K; Nikaido T
Biol Pharm Bull; 2002 Dec; 25(12):1651-4. PubMed ID: 12499659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]